Ignite Creation Date:
2025-12-25 @ 12:35 AM
Ignite Modification Date:
2026-05-16 @ 8:38 PM
Study NCT ID:
NCT02251067
Status:
COMPLETED
Last Update Posted:
2017-03-28
First Post:
2014-09-24
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Phase 2 Study to Evaluate Safety & Efficacy of VPI-2690B in Diabetic Nephropathy Patients
Sponsor:
Vascular Pharmaceuticals, Inc.
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
VPI-CLIN-201-AD
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None